Search

everythinglearnresearchcommunity

for

Search:↓

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Medications for PCOS don't seem to raise heart disease risk.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

The new model detects hair clusters more accurately and efficiently, helping with early hair loss treatment and diagnosis.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Cosmetic hair treatments can increase hair testosterone levels, while natural hair color does not affect it.

The trial aims to understand how obesity and lifestyle affect circadian rhythms in people with schizophrenia and bipolar disorder.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

EF and PXE not closely related.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

A 3-month treatment improved PCOS symptoms and reduced certain immune proteins.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

Some vaccines might rarely cause hair loss, more research is needed.

Finasteride works best in 6 months and lasts 6 years.

Finasteride effectively treats central serous chorioretinopathy.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.